Literature DB >> 12535371

Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system.

Arun Paul Amar1, Berislav V Zlokovic, Michael L J Apuzzo.   

Abstract

The amalgam of molecular biology and neurosurgery offers immense promise for neurorestoration and the management of neurodegenerative deficiencies, developmental disorders, neoplasms, stroke, and trauma. This article summarizes present strategies for and impediments to gene therapy and stem cell therapy of the central nervous system and advances the concept of a potential new approach, namely endovascular restorative neurosurgery. The objectives of gene transfer to the central nervous system are efficient transfection of host cells, selective sustained expression of the transgene, and lack of toxicity or immune excitation. The requisite elements of this process are the identification of candidate diseases, the construction of vehicles for gene transfer, regulated expression, and physical delivery. In the selection of target disorders, the underlying genetic events to be overcome, as well as their spatial and temporal distributions, must be considered. These factors determine the requirements for the physical dispersal of the transgene, the duration of transgene expression, and the quantity of transgene product needed to abrogate the disease phenotype. Vehicles for conveying the transgene to the central nervous system include viral vectors (retroviruses, lentiviruses, adenoviruses, adeno-associated viruses, and herpes simplex virus), liposomes, and genetically engineered cells, including neural stem cells. Delivery of the transgene into the brain presents several challenges, including limited and potentially risky access through the cranium, sensitivity to volumetric changes, restricted diffusion, and the blood-brain barrier. Genetic or cellular therapeutic agents may be injected directly into the brain parenchyma (via stereotaxy or craniotomy), into the cerebrospinal fluid (in the ventricles or cisterns), or into the bloodstream (intravenously or intra-arterially). The advantages of the endovascular route include the potential for widespread distribution, the ability to deliver large volumes, limited perturbation of neural tissue, and the feasibility of repeated administration.

Entities:  

Mesh:

Year:  2003        PMID: 12535371     DOI: 10.1227/01.neu.0000043698.86548.a0

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke.

Authors:  Yuhtaka Fukuda; Nobutaka Horie; Katsuya Satoh; Susumu Yamaguchi; Youichi Morofuji; Takeshi Hiu; Tsuyoshi Izumo; Kentaro Hayashi; Noriyuki Nishida; Izumi Nagata
Journal:  Cell Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.046

2.  Culture and identification of monoclonal neural stem cells derived from cerebral cortex.

Authors:  Kaixiong Tao; Jingbo Chen; Guobin Wang; Xiaogang Shu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 3.  The evolution and future of minimalism in neurological surgery.

Authors:  Charles Y Liu; Michael Y Wang; Michael L J Apuzzo
Journal:  Childs Nerv Syst       Date:  2004-07-30       Impact factor: 1.475

4.  Current status and future prospect of endovascular neurosurgery.

Authors:  Young Il Jeon; Do Hoon Kwon
Journal:  J Korean Neurosurg Soc       Date:  2008-02-20

Review 5.  Intracarotid delivery of drugs: the potential and the pitfalls.

Authors:  Shailendra Joshi; Phillip M Meyers; Eugene Ornstein
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

6.  Treatment of aganglionic megacolon mice via neural stem cell transplantation.

Authors:  Xiaogang Shu; Qingliang Meng; Huijuan Jin; Jingbo Chen; Yong Xiao; Jintong Ji; Tao Qin; Guobin Wang
Journal:  Mol Neurobiol       Date:  2013-03-20       Impact factor: 5.590

Review 7.  Stem cell transplantation enhances endogenous brain repair after experimental stroke.

Authors:  Nobutaka Horie; Takeshi Hiu; Izumi Nagata
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-01-23       Impact factor: 1.742

Review 8.  Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke.

Authors:  Arun Paul Amar; John H Griffin; Berislav V Zlokovic
Journal:  Front Cell Neurosci       Date:  2015-09-02       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.